33
Participants
Start Date
April 15, 2018
Primary Completion Date
July 31, 2020
Study Completion Date
July 31, 2020
CXA-10
CXA-10 (10-nitro-9(E)-octadec-9-enoic acid) is a specific isomer of nitro-oleic acid (OA-NO2)
Albert Einstein College of Medicine, Montefiore, The Bronx
Northeast Clinical Research Center (NCRC), Bethlehem
University of Pennsylvania, Philadelphia
A.I. duPont Hospital for Children, Wilmington
Virginia Commonwealth University, Richmond
Metrolina Nephrology Associates, Charlotte
Levine Children's Hospital, Charlotte
University of Miami, Miami
Alabama Neurology Consultants, Huntsville
Nephrology Associates, Franklin
Cleveland Clinic, Cleveland
St. Clair Nephrology Research, Roseville
University of Michigan, Ann Arbor
Nephrology Associates of Northern Illinois and Indiana (NANI), Chicago
Clinical Research Consultants-KCMO, Kansas City
Northwest Louisiana Nephrology, Shreveport
Renal Disease Research Institute, DeSoto
Texas Tech, Amarillo
El Paso Medical Research, El Paso
Stanford University, Palo Alto
The Polyclinic, Seattle
Providence Sacred Heart Medical Center and Children's Hospital, Spokane
Cedars Sinai Medical Center, Los Angeles
Kidney Care and Transplant Services of New England, Springfield
Lead Sponsor
Collaborators (4)
Kidney Research Network, formerly NephCure Accelerating Cures Institute
UNKNOWN
Medpace, Inc.
INDUSTRY
MicroConstants
UNKNOWN
Arkana Labs
UNKNOWN
NephCure Kidney International
UNKNOWN
Complexa, Inc.
INDUSTRY